AKTX- Akari Therapeutics Plc
Akari Therapeutics Plc (AKTX) has 7 insiders with recent SEC Form 4 filings, including 8 buys and 0 sells. AKTX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 618.7K | $5.00M | - | |
| Dir | 618.7K | $5.00M | - | |
| 10% | 618.7K | $5.00M | - | |
| Dir | 154.7K | $1.25M | - | |
| Dir | 123.7K | $999.7K | - |
Activity
Buys and sells only
Transactions
5 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 | Gaslightwala Abizer73 | CEO | Buy | 21,000 | $0.93 | $19,540.00 | +2.4% | -50.0% | - | |
| Jun 24, 2025 | Gaslightwala Abizer73 | President &CEO | Buy | 6,146 | $1.16 | $7,119.93 | +1.1% | -29.4% | +827.2% | |
| Jun 20, 2025 | Gaslightwala Abizer73 | President &CEO | Buy | 10,000 | $1.20 | $12,000.00 | +3.8% | -28.6% | +902.7% | |
| Jun 17, 2025 | Gaslightwala Abizer73 | President &CEO | Buy | 15,000 | $1.20 | $18,000.00 | +6.1% | -34.3% | +916.9% | |
| Sep 18, 2015 | Cohen Mark S | Director | Buy | 1,055,600 | $0.19 | $200,036.20 | New | - | - |